IMPACT AND MANAGEMENT OF DRUG-DRUG INTERACTIONS BETWEEN APIXABAN OR RIVAROXABAN AND SYSTEMIC AZOLE ANTIFUNGAL THERAPY.

被引:0
|
作者
Stilwell, Allison [1 ]
Goldman, Svetlana [1 ]
Palkimas, Surabhi [1 ]
机构
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E61 / E61
页数:1
相关论文
共 50 条
  • [21] Predicting drug-drug interactions with physiologically based pharmacokinetic/pharmacodynamic modelling and optimal dosing of apixaban and rivaroxaban with dronedarone co-administration
    Wen, Hai-Ni
    He, Qing-Feng
    Xiang, Xiao-Qiang
    Jiao, Zheng
    Yu, Jian-Guang
    THROMBOSIS RESEARCH, 2022, 218 : 24 - 34
  • [22] Case report: Drug-drug interaction between alectinib and apixaban in NSCLC
    Gulikers, J. L.
    Slikkerveer, M.
    Winckers, K.
    Hendriks, L. E. L.
    Dursun, S.
    Croes, S.
    van Geel, R. M. J. M.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 7
  • [23] Drug-drug interactions. Interactions between xenobiotics
    Haen, E.
    NERVENARZT, 2014, 85 (04): : 417 - +
  • [24] Pharmacokinetic drug-drug interaction between olaparib and apixaban: a case report
    Berge, M.
    Giraud, J. S.
    De Percin, S.
    Puszkiel, A.
    Thomas-Schoemann, A.
    Blanchet, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (05) : 519 - 521
  • [25] The impact of metabolic pathways to drug-drug interactions
    Wittmann, M.
    Koestlbacher, A.
    Hader, A.
    Koeber, R.
    Haen, E.
    PHARMACOPSYCHIATRY, 2011, 44 (06)
  • [26] Drug-drug interactions in pharmacologic management of gastroparesis
    Youssef, A. S.
    Parkman, H. P.
    Nagar, S.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (11): : 1528 - 1541
  • [27] Methadone and antiretroviral therapy: Drug-drug interactions and impact on methadone program in Malaysia
    Abd Rashid, R.
    Jaafar, S. K. R.
    Habil, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 47 - 48
  • [29] Drug-drug interactions between antiepileptics and cannabinoids
    Miziak, Barbara
    Walczak, Aleksandra
    Szponar, Jaroslaw
    Pluta, Ryszard
    Czuczwar, Stanislaw J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 407 - 415
  • [30] DRUG-DRUG INTERACTION DATABASES: SENSITIVITY AND SPECIFICITY TO DETECT MANIFEST DRUG-DRUG INTERACTIONS, RELIABILITY RATINGS AND MANAGEMENT STRATEGIES OF POTENTIAL DRUG-DRUG INTERACTIONS
    Ocovska, Z.
    Marikova, M.
    Kukralova, K.
    Vlcek, J.
    VALUE IN HEALTH, 2022, 25 (01) : S140 - S141